Conversely, there is evidence of RUNX1 over-expression in various cases of ER negative and triple negative breast cancer, supporting a pro-oncogenic role of RUNX1 correlated with poor prognosis and survival [104,105,106,107,108]. This evidence concerns the gene RUNX1 and triple-negative breast carcinoma.